Washington, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)National Center for Health Research Inc, founded in 1999, is a small nonprofit in the Social Science sector that reported $489K in total revenue in fiscal year 2023. Revenue surged 54% from the prior year, signaling strong growth momentum. Expenses of $611K exceeded revenue, resulting in a 25% operating deficit.
To improve the health and safety of adults and children by using objective, research-based information to encourage new, more effective programs & policies.
ACTION NOW: IMPROVING THE SAFETY AND EFFECTIVENESS OF MEDICAL PRODUCTS. THIS PROGRAM PAYS FOR STAFF WHO FOCUS ON ANALYZING THE STRENGTHS AND WEAKNESSES OF CURRENT STANDARDS FOR FDA APPROVAL AND...
ACTION NOW: IMPROVING THE SAFETY AND EFFECTIVENESS OF MEDICAL PRODUCTS. THIS PROGRAM PAYS FOR STAFF WHO FOCUS ON ANALYZING THE STRENGTHS AND WEAKNESSES OF CURRENT STANDARDS FOR FDA APPROVAL AND POST-MARKET SURVEILLANCE OF DRUGS, BIOLOGICS, AND MEDICAL DEVICES. THIS WORK INCLUDES ANALYZING DATA, SYNTHESIZING RESEARCH CONDUCTED BY OTHERS, PRESENTATIONS AT PUBLIC MEETINGS, AND SHARING INFORMATION WITH HEALTHCARE PROFESSIONALS, HEALTH POLICY EXPERTS, AND OPINION LEADERS.
IMPLANTS: THIS PROJECT FOCUSES ON HELPING WOMEN OBTAIN HEALTH INSURANCE COVERAGE FOR MEDICALLY NECESSARY SURGERY, WHICH CONFORMS WITH THE AFFORDABLE CARE ACT. THIS PROJECT ALSO INCLUDES REVIEWING AND...
IMPLANTS: THIS PROJECT FOCUSES ON HELPING WOMEN OBTAIN HEALTH INSURANCE COVERAGE FOR MEDICALLY NECESSARY SURGERY, WHICH CONFORMS WITH THE AFFORDABLE CARE ACT. THIS PROJECT ALSO INCLUDES REVIEWING AND EXPLAINING NEW DATA PERTAINING TO THE RISKS OF IMPLANTS THAT CAN CAUSE CANCER AND OTHER SERIOUS CONDITIONS, AND PROVIDING THAT INFORMATION TO PATIENTS, HEALTHCARE PROVIDERS, JOURNALISTS, AND THE GENERAL PUBLIC. THE GOAL OF THE PROJECT IS TO ENSURE THAT WOMEN WITH HARMFUL MEDICAL IMPLANTS HAVE ACCURATE INFORMATION AND ACCESS TO MEDICALLY NECESSARY TREATMENT, AS THE LAW REQUIRES.
CANCER PREVENTION AND TREATMENT FUND PROGRAM IS FOCUSED ON CONDUCTING RESEARCH AND EXPLAINING RESEARCH RESULTS, HELPING INDIVIDUALSPREVENT CANCER, PREVENT CANCER FROM RETURNING, AND GET THE BEST...
CANCER PREVENTION AND TREATMENT FUND PROGRAM IS FOCUSED ON CONDUCTING RESEARCH AND EXPLAINING RESEARCH RESULTS, HELPING INDIVIDUALSPREVENT CANCER, PREVENT CANCER FROM RETURNING, AND GET THE BEST POSSIBLE MEDICAL CARE. THE PROGRAM ANALYZES RESEARCHBASED INFORMATIONFROM PEERREVIEWED SOURCES AND PROVIDES ANALYSES OF HEALTH POLICIES. THE PROGRAM ALSO PROVIDES A FREE ONLINE CANCER HOTLINE AND OTHERPERSONALIZED ASSISTANCE, AND HELPS PROFESSIONALS GIVE PATIENTS THE BEST POSSIBLE CARE THROUGH PRESENTATIONS AT PUBLIC MEETINGS; HOSTINGWORKSHOPS AND WEBINARS; AND WRITING REPORTS AND ARTICLES. THIS PROGRAM WILL ALSO INCLUDE TECHNICAL SUPPORT TO ORGANIZATIONS SERVINGBREAST CANCER PATIENTS OF COLOR.PATIENT CENTERED OUTCOME RESEARCH INSTITUTE SUPPORTED LONG COVID PROJECT BRINGS TOGETHER PATIENTS,RESEARCHERS, AND HEALTHCARE PROVIDERS TO SHARE INFORMATION ABOUT LONG COVID (ALSO SOMETIMES CALLED COVID LONG HAULERS).
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $489,483 | $317,127 | +0.5% |
| Expenses | $610,859 | $688,788 | -0.1% |
| Net Income | $-121,376 | $-371,661 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Diana Zuckerman | President | 40.00 |
Officer
Director
|
$125,000 | $14,107 | $139,107 |
| Brandel France De Bravo | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Duchy Trachtenberg | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Daniel Fox | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Linda Sonntag | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Susanne Wilke | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Sarah Deutsch | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Nancy Hardt | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Benjamin Gittermin | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Susan F Wood | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Judith Harris | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Alan Mendelson | Treasurer | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $489,483 | $610,859 | $671,603 | $-121,376 |
| 2022 | $317,127 | $688,788 | $767,590 | $-371,661 |
| 2021 | $1,055,773 | $549,680 | $1,163,401 | $506,093 |
| 2020 | $555,296 | $535,225 | $603,815 | $20,071 |
| 2019 | $767,051 | $701,010 | $597,796 | $66,041 |
| 2018 | $715,191 | $685,669 | $492,583 | $29,522 |
| 2017 | $653,547 | $703,339 | $486,103 | $-49,792 |
Compare National Center for Health Research Inc with other nonprofits in District of Columbia and across the country.